Subscribe
shutterstock_734924050_ricochet64
ricochet64 / Shutterstock.com
10 January 2022AmericasAlex Baldwin

Scientist admits to Monsanto trade secret espionage

A former Monsanto employee has pled guilty to conspiring to steal trade secrets from the biotech company in order to share the information with the Chinese government.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
European Commission clears Bayer’s $62.5bn Monsanto buy
22 March 2018   The European Commission has approved Bayer’s $62.5 billion acquisition of agrochemical company Monsanto, subject to conditions.
Americas
Federal Circuit rejects Monsanto’s soybean appeal
11 January 2018   The US Court of Appeals for the Federal Circuit has confirmed that claims within a patent relating to genetically modified soybeans are invalid due to anticipation and obviousness.
Americas
AltaThera hits competitor with trade secret suit
1 September 2022   Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Big Pharma
European Commission clears Bayer’s $62.5bn Monsanto buy
22 March 2018   The European Commission has approved Bayer’s $62.5 billion acquisition of agrochemical company Monsanto, subject to conditions.
Americas
Federal Circuit rejects Monsanto’s soybean appeal
11 January 2018   The US Court of Appeals for the Federal Circuit has confirmed that claims within a patent relating to genetically modified soybeans are invalid due to anticipation and obviousness.
Americas
AltaThera hits competitor with trade secret suit
1 September 2022   Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.

More on this story

Big Pharma
European Commission clears Bayer’s $62.5bn Monsanto buy
22 March 2018   The European Commission has approved Bayer’s $62.5 billion acquisition of agrochemical company Monsanto, subject to conditions.
Americas
Federal Circuit rejects Monsanto’s soybean appeal
11 January 2018   The US Court of Appeals for the Federal Circuit has confirmed that claims within a patent relating to genetically modified soybeans are invalid due to anticipation and obviousness.
Americas
AltaThera hits competitor with trade secret suit
1 September 2022   Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.

More features

Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages